FDA Analyte-Specific Reagent Guidance Spells Out Small Lab Fundamentals

Labeling and promotional material for Class I analyte-specific reagents may bear information clarifying that FDA does not require premarket review of the tests, according to the agency

More from Archive

More from Medtech Insight